Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease

World J Gastroenterol. 2019 Jun 28;25(24):3056-3068. doi: 10.3748/wjg.v25.i24.3056.

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease worldwide. However, to date, there is no ideal therapy for this disease.

Aim: To study the effects of Si-Ni-San freeze-dried powder on high fat diet-induced NAFLD in mice.

Methods: Twenty-four male C57BL/6 mice were randomized into three groups of eight. The control group (CON) was allowed ad libitum access to a normal chow diet. The high fat diet group (FAT) and Si-Ni-San group (SNS) were allowed ad libitum access to a high fat diet. The SNS group was intragastrically administered Si-Ni-San freeze-dried powder (5.0 g/kg) once daily, and the CON and FAT groups were intragastrically administered distilled water. After 12 wk, body weight, liver index, visceral fat index, serum alanine aminotransferase (ALT), portal lipopoly-saccharide (LPS), liver tumor necrosis factor (TNF)-α and liver triglycerides were measured. Intestinal microbiota were analyzed using a 16S r DNA sequencing technique.

Results: Compared with the FAT group, the SNS group exhibited decreased body weight, liver index, visceral fat index, serum ALT, portal LPS, liver TNF-α and liver triglycerides (P < 0.05). Intestinal microbiota analysis showed that the SNS group had different bacterial composition and function compared with the FAT group. In particular, Oscillospira genus was a bacterial biomarker of SNS group samples.

Conclusion: The beneficial effects of Si-Ni-San freeze-dried powder on high fat diet-induced NAFLD in mice may be associated with its anti-inflammatory and changing intestinal microbiota effects.

Keywords: High fat diet; Inflammation; Intestinal microbiota; Nonalcoholic fatty liver disease; Si-Ni-San.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal
  • Drug Compounding / methods*
  • Drug Evaluation, Preclinical
  • Drugs, Chinese Herbal / therapeutic use*
  • Freeze Drying
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / physiology
  • Humans
  • Male
  • Mice
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / etiology
  • Non-alcoholic Fatty Liver Disease / microbiology
  • Powders
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Drugs, Chinese Herbal
  • Powders
  • shigyaku-san